GO	[-10.12 -0.97]	[-0.97 -0.59]	[-0.59 -0.32]	[-0.32 -0.10]	[-0.10 0.00]	[0.00 0.00]	[0.00 0.16]	[0.16 0.42]	[0.42 0.80]	[0.80 1.88]	[1.88 23.61]
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	-0.543	6.040	8.004	5.149	-1.143	-5.456	-0.543	0.301	-2.599	-6.693	-6.674
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	0.514	5.130	8.832	1.156	-3.840	-6.322	-1.062	1.156	-0.674	-2.746	-4.507
BENPORATH_PROLIFERATION BENPORATH_PROLIFERATION	-2.728	1.568	1.325	3.449	-4.049	-6.151	-0.528	2.420	4.227	-0.904	-4.933
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	-3.761	-1.274	1.813	1.074	-1.608	-5.817	0.291	3.858	6.084	-0.311	-3.747
SCHUHMACHER_MYC_TARGETS_UP SCHUHMACHER_MYC_TARGETS_UP	5.780	7.686	0.724	0.724	-1.707	-3.319	-1.707	-1.225	-0.596	-3.319	-2.355
PUJANA_XPRSS_INT_NETWORK PUJANA_XPRSS_INT_NETWORK	-1.281	-0.813	0.722	3.244	-1.926	-6.985	-0.486	4.345	3.961	-0.269	-4.762
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	-0.946	3.039	1.227	4.423	-2.917	-7.863	-0.946	1.036	1.904	-0.463	-4.020
FUJII_YBX1_TARGETS_DN FUJII_YBX1_TARGETS_DN	-3.032	0.309	0.962	1.559	-1.011	-8.030	0.797	4.987	2.307	-0.294	-4.857
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	-0.959	3.895	1.287	2.566	-1.192	-7.361	1.287	1.085	0.590	-1.784	-6.066
WINNEPENNINCKX_MELANOMA_METASTASIS_UP WINNEPENNINCKX_MELANOMA_METASTASIS_UP	-1.162	-0.556	1.207	3.162	-2.170	-5.496	0.395	2.827	4.671	-1.162	-5.478
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	-0.302	4.181	3.486	1.765	-0.829	-6.758	-0.517	2.012	-0.659	-1.837	-5.726
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	-0.791	0.487	1.649	2.503	-2.397	-5.183	-0.791	3.906	2.827	-1.011	-5.166
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	-4.070	-2.094	-0.962	0.845	-1.186	-4.770	0.334	7.804	3.321	1.017	-0.602
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	-1.637	0.767	2.879	3.881	-1.347	-6.401	1.114	0.767	0.491	0.285	-6.381
MOOTHA_VOXPHOS MOOTHA_VOXPHOS	1.297	6.884	2.312	1.943	-2.621	-1.933	-1.029	-0.505	-1.029	-3.610	-2.612
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	-5.053	0.270	-0.562	-0.562	-1.095	-8.239	1.234	3.006	3.321	1.660	0.274
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	0.721	5.002	2.530	2.835	-3.102	-5.149	-0.354	-0.262	-0.262	-1.487	-4.333
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	-3.592	-1.528	-1.028	0.781	-2.597	-4.203	0.781	3.160	6.607	1.765	-1.019
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	0.708	-2.759	-1.474	-1.474	-0.712	-1.173	-2.759	-1.474	1.539	2.081	10.233
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	-2.573	-1.254	0.788	3.080	-1.609	-3.227	-0.388	4.757	3.468	-0.727	-3.215
WHITFIELD_CELL_CYCLE_G2_M WHITFIELD_CELL_CYCLE_G2_M	-0.889	-1.612	0.270	1.234	-2.291	-5.053	0.721	0.875	7.717	1.439	-3.161
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	-0.752	-0.581	0.630	1.379	-2.224	-4.632	-0.328	4.559	5.399	-1.201	-3.214
DANG_MYC_TARGETS_UP DANG_MYC_TARGETS_UP	2.168	6.863	1.864	1.325	-2.188	-4.251	-0.813	-0.813	-0.813	-1.063	-2.722
RAMALHO_STEMNESS_UP RAMALHO_STEMNESS_UP	-0.672	0.386	3.444	3.782	-0.844	-6.797	0.926	1.299	0.386	-1.549	-4.218
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	-1.731	-0.693	-1.124	-0.293	-1.403	-4.485	-1.731	-0.293	2.587	9.162	1.264
PODAR_RESPONSE_TO_ADAPHOSTIN_UP PODAR_RESPONSE_TO_ADAPHOSTIN_UP	-2.759	-1.173	-0.292	-0.921	-0.541	-4.988	-0.402	0.310	2.081	10.197	-0.289
PUJANA_BRCA_CENTERED_NETWORK PUJANA_BRCA_CENTERED_NETWORK	-0.829	-0.443	0.936	3.050	-1.843	-4.900	0.413	1.417	3.447	-0.443	-4.886
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	-2.395	1.635	1.379	0.580	-0.940	-5.692	0.580	1.635	3.622	-0.940	-3.640
VERHAAK_AML_WITH_NPM1_MUTATED_UP VERHAAK_AML_WITH_NPM1_MUTATED_UP	-0.432	-1.659	-0.898	-0.714	-3.345	-1.367	-1.367	-0.560	0.606	8.597	4.220
KONDO_PROSTATE_CANCER_WITH_H3K27ME3 KONDO_PROSTATE_CANCER_WITH_H3K27ME3	-1.260	-2.597	-1.260	-1.528	1.765	4.934	-0.517	-1.528	-2.597	0.635	5.359
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	7.869	1.726	1.726	0.856	-0.958	-1.836	-2.510	-1.336	-1.336	-1.336	-1.329
MORI_IMMATURE_B_LYMPHOCYTE_DN MORI_IMMATURE_B_LYMPHOCYTE_DN	-2.065	0.504	1.168	0.349	-2.065	-3.776	-1.127	2.901	3.794	0.914	-2.761
LI_DCP2_BOUND_MRNA LI_DCP2_BOUND_MRNA	0.995	4.510	1.899	-0.522	-1.448	-3.652	-0.522	1.899	-1.448	-0.351	-3.641
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN	-1.659	-3.939	0.370	0.606	0.479	-3.939	1.741	3.836	2.542	0.370	-2.817
BROWN_MYELOID_CELL_DEVELOPMENT_UP BROWN_MYELOID_CELL_DEVELOPMENT_UP	-1.556	-0.475	-0.475	-1.010	-1.901	-3.323	-1.010	0.587	1.306	10.209	0.593
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	-2.341	-0.975	1.457	-0.320	-1.543	-2.852	0.659	2.581	4.010	1.226	-4.179
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	-2.510	-1.836	0.856	3.807	-0.958	-2.510	-0.301	4.310	1.112	-0.458	-2.502
WANG_CLIM2_TARGETS_DN WANG_CLIM2_TARGETS_DN	-3.808	0.409	-0.392	2.685	-0.293	-3.223	0.987	4.395	1.385	-1.572	-2.704
WHITFIELD_CELL_CYCLE_G2 WHITFIELD_CELL_CYCLE_G2	-1.045	-1.601	0.434	1.481	-0.277	-5.770	-0.648	2.261	5.100	0.434	-2.346
HOLLERN_SQUAMOUS_BREAST_TUMOR HOLLERN_SQUAMOUS_BREAST_TUMOR	0.301	-2.026	-2.440	-1.669	1.406	5.347	0.660	-1.362	-2.922	-0.301	3.093
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	-1.097	-0.882	2.577	1.114	-3.315	-4.595	-0.548	1.769	4.246	-0.548	-0.542
JISON_SICKLE_CELL_DISEASE_DN JISON_SICKLE_CELL_DISEASE_DN	-2.411	0.736	2.804	3.117	-1.386	-3.971	0.593	1.270	1.270	-2.021	-2.008
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	0.539	3.428	2.939	1.681	-1.363	-2.862	0.763	-1.363	-0.935	-1.963	-1.956
WHITFIELD_CELL_CYCLE_S WHITFIELD_CELL_CYCLE_S	-0.904	-0.904	0.725	1.103	-1.452	-4.049	0.568	2.744	3.829	0.319	-4.034
BURTON_ADIPOGENESIS_5 BURTON_ADIPOGENESIS_5	3.447	4.305	1.163	1.163	-1.843	-2.982	0.291	-2.351	-1.099	-0.829	-1.424
WU_CELL_MIGRATION WU_CELL_MIGRATION	-3.253	-1.594	-0.851	-1.062	0.399	-0.402	-0.851	-1.925	1.156	3.280	6.446
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	-2.613	-0.786	-0.315	1.244	-2.613	-2.613	-0.786	0.288	0.459	1.982	4.506
KIM_ALL_DISORDERS_DURATION_CORR_DN KIM_ALL_DISORDERS_DURATION_CORR_DN	1.404	2.538	3.988	1.656	-1.731	-2.145	-0.652	-0.360	-0.360	-3.226	-2.625
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	3.102	3.102	0.597	1.620	-0.431	-1.948	-0.431	-0.729	-1.948	-1.948	-1.943
GOLDRATH_HOMEOSTATIC_PROLIFERATION GOLDRATH_HOMEOSTATIC_PROLIFERATION	0.903	1.103	1.103	2.116	-0.392	-6.151	-0.528	0.725	1.325	-1.807	-3.312
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	-1.899	-0.921	1.169	-0.274	-1.899	-5.650	0.954	2.923	1.948	1.169	-0.915
HUANG_GATA2_TARGETS_UP HUANG_GATA2_TARGETS_UP	-2.312	-1.214	0.675	0.845	-1.883	-5.066	0.292	0.675	0.675	5.787	0.403
RIGGI_EWING_SARCOMA_PROGENITOR_DN RIGGI_EWING_SARCOMA_PROGENITOR_DN	-0.302	-1.260	-1.028	-1.837	0.396	-0.517	-4.911	-0.829	3.160	2.275	3.848
LEE_EARLY_T_LYMPHOCYTE_UP LEE_EARLY_T_LYMPHOCYTE_UP	-2.071	-2.071	-0.668	1.426	-1.214	-2.671	0.270	3.130	5.428	-0.334	-0.663
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	-1.872	-0.512	-0.687	-1.872	-0.373	-0.265	-2.336	-1.487	0.976	2.291	7.542
VILLANUEVA_LIVER_CANCER_KRT19_UP VILLANUEVA_LIVER_CANCER_KRT19_UP	-2.101	-2.101	-0.327	2.953	-0.732	-2.101	1.126	2.343	3.629	-0.732	-2.510
PECE_MAMMARY_STEM_CELL_UP PECE_MAMMARY_STEM_CELL_UP	1.120	7.799	0.565	0.426	-0.959	-4.560	-1.231	0.426	-0.553	-1.231	-0.729
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	-0.567	0.610	1.007	2.456	0.322	-4.775	-1.034	1.801	1.510	-1.034	-3.664
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	-0.983	-1.635	-1.635	-2.072	-1.277	-0.400	-0.552	-0.552	2.668	7.204	1.200
XIE_ST_HSC_S1PR3_OE_UP XIE_ST_HSC_S1PR3_OE_UP	-0.442	-2.021	-0.728	-2.021	-0.442	-1.132	-1.386	-0.572	0.468	3.446	7.571
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	1.431	1.963	2.578	0.985	-1.074	-3.193	-1.706	2.578	-1.074	-1.706	-2.106
MEISSNER_NPC_HCP_WITH_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K27ME3	-0.842	-1.198	-1.675	-0.383	0.748	8.503	-0.244	-1.675	-0.842	-1.675	1.604
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	-0.865	-0.865	-0.865	-0.397	-3.319	-2.363	-0.596	1.243	1.243	6.390	0.524
DAZARD_UV_RESPONSE_CLUSTER_G6 DAZARD_UV_RESPONSE_CLUSTER_G6	-1.362	-0.638	1.197	0.482	-0.478	-5.984	-0.638	2.915	3.272	0.359	-1.353
PUJANA_BREAST_CANCER_LIT_INT_NETWORK PUJANA_BREAST_CANCER_LIT_INT_NETWORK	-1.828	-1.029	2.760	1.136	-0.373	-4.192	0.687	2.028	0.896	-0.250	-3.134
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	-1.355	0.524	1.164	0.524	-0.360	-4.151	1.164	3.223	0.524	-0.521	-4.139
KONG_E2F3_TARGETS KONG_E2F3_TARGETS	-1.278	-1.278	0.771	-0.476	0.412	-2.994	-0.678	5.355	2.204	0.575	-2.984
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	-1.341	-2.413	-1.081	-1.341	-0.676	-0.521	-1.081	-0.521	2.484	7.238	1.442
WELCSH_BRCA1_TARGETS_DN WELCSH_BRCA1_TARGETS_DN	1.516	4.210	1.272	1.051	-0.784	-3.796	-0.594	0.676	-0.442	-2.034	-3.080
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	0.328	-0.664	-1.360	-2.065	-0.856	-2.065	-0.856	-1.360	1.789	4.901	3.725
TAVOR_CEBPA_TARGETS_UP TAVOR_CEBPA_TARGETS_UP	-2.156	-0.316	-1.362	0.286	-0.865	-1.362	-2.156	0.286	1.017	6.458	1.022
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	-0.691	-0.691	-1.868	-0.981	-1.868	-1.364	-0.313	0.289	-0.313	8.421	2.044
CROONQUIST_IL6_DEPRIVATION_DN CROONQUIST_IL6_DEPRIVATION_DN	-1.227	-1.227	0.816	1.318	-1.227	-2.919	-0.642	3.991	1.318	1.318	-2.910
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	-0.443	2.326	1.417	0.936	0.735	-4.900	-2.351	1.695	-0.613	0.291	-2.340
UDAYAKUMAR_MED1_TARGETS_UP UDAYAKUMAR_MED1_TARGETS_UP	0.330	1.406	0.763	4.504	-1.188	-4.483	-0.384	0.954	0.451	-1.188	-2.917
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	-0.310	-2.952	-3.516	-2.468	0.509	2.128	0.292	-1.382	1.169	1.612	2.731
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	-3.027	0.301	-0.751	3.144	-1.252	-3.725	-0.566	2.789	1.575	0.892	-0.745
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP	-0.528	-0.528	0.903	-0.528	-4.049	-4.049	-0.392	2.116	0.433	4.227	0.323
ELVIDGE_HYPOXIA_DN ELVIDGE_HYPOXIA_DN	1.325	4.643	1.325	1.103	0.319	-3.326	0.319	-1.452	-0.528	-2.228	-2.217
KAAB_FAILED_HEART_ATRIUM_DN KAAB_FAILED_HEART_ATRIUM_DN	1.351	3.132	2.151	-0.515	-1.133	-2.698	-0.515	1.126	-0.381	-0.381	-4.894
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	0.976	1.789	4.582	0.290	-0.451	-4.442	-0.869	0.576	-0.451	-1.167	-2.000
PYEON_HPV_POSITIVE_TUMORS_UP PYEON_HPV_POSITIVE_TUMORS_UP	-2.331	-0.506	-0.714	0.259	-0.506	-2.331	-0.984	3.282	5.190	0.946	-1.322
RHODES_UNDIFFERENTIATED_CANCER RHODES_UNDIFFERENTIATED_CANCER	-0.252	0.539	5.087	0.357	-0.626	-2.862	-1.963	0.763	0.763	-0.252	-2.854
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	1.730	1.730	2.330	2.019	-1.146	-4.405	-0.363	0.477	-1.463	-1.463	-1.454
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	-1.528	-0.659	-0.659	-0.399	-2.597	-3.592	0.781	0.301	1.124	5.744	1.332
JISON_SICKLE_CELL_DISEASE_UP JISON_SICKLE_CELL_DISEASE_UP	0.309	0.409	0.662	-1.288	-2.718	-5.298	-0.392	-0.660	2.995	1.610	1.867
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	-1.615	-1.615	-1.615	-0.867	-1.327	-1.615	0.502	0.389	0.783	3.928	4.702
LEE_LIVER_CANCER_SURVIVAL_DN LEE_LIVER_CANCER_SURVIVAL_DN	-1.230	0.564	2.495	1.457	-0.363	-6.164	-0.479	0.564	1.941	-0.270	-2.191
EPPERT_PROGENITOR EPPERT_PROGENITOR	-1.231	1.351	1.880	0.426	-1.953	-5.734	0.565	1.120	0.727	0.912	-1.550
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	-0.663	-0.663	-0.663	-0.663	0.362	9.401	-0.247	-0.663	-0.663	-0.663	-0.246
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	-2.606	-0.468	0.577	0.577	-1.807	-2.178	-0.262	1.971	4.602	1.065	-2.165
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	-0.791	4.301	0.367	1.178	0.367	-5.183	-0.459	0.791	0.487	-0.339	-2.901
DANG_REGULATED_BY_MYC_UP DANG_REGULATED_BY_MYC_UP	0.560	5.189	0.790	1.062	-0.606	-2.820	-0.240	-0.606	-0.390	-2.820	-0.905
GAVIN_FOXP3_TARGETS_CLUSTER_T7 GAVIN_FOXP3_TARGETS_CLUSTER_T7	-1.828	3.596	1.405	0.896	-1.381	-4.192	-0.250	0.687	0.896	-0.752	-1.023
WHITFIELD_CELL_CYCLE_M_G1 WHITFIELD_CELL_CYCLE_M_G1	-1.609	0.610	1.470	0.610	-0.963	-5.192	0.331	3.080	0.990	-0.273	-1.601
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	-0.301	-1.650	0.612	1.942	-1.650	-3.943	0.441	1.318	1.615	1.052	-2.189
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	0.578	-3.194	-0.797	-2.253	0.253	-0.541	-0.797	-0.797	1.055	4.904	1.357
BROCKE_APOPTOSIS_REVERSED_BY_IL6 BROCKE_APOPTOSIS_REVERSED_BY_IL6	-0.851	-0.490	-0.490	0.612	-2.145	-3.940	-0.258	1.656	1.173	4.824	-1.086
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	-1.016	-1.016	0.852	0.283	-3.093	-4.677	1.272	0.676	1.272	2.703	0.286
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4 PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	-2.040	-0.323	-2.040	-0.651	-0.651	-0.465	-0.465	-0.651	-0.651	4.999	4.531
IRITANI_MAD1_TARGETS_DN IRITANI_MAD1_TARGETS_DN	2.134	2.134	2.640	-0.228	-1.158	-1.907	-0.411	-0.228	-0.411	-1.907	-1.901
SERVITJA_ISLET_HNF1A_TARGETS_UP SERVITJA_ISLET_HNF1A_TARGETS_UP	1.481	-1.045	-1.045	-2.833	-0.277	0.706	-1.045	-2.358	-0.498	1.983	4.712
RICKMAN_HEAD_AND_NECK_CANCER_C RICKMAN_HEAD_AND_NECK_CANCER_C	0.439	-1.055	-2.288	-2.913	0.593	2.412	-0.418	-1.787	-0.582	0.983	4.004
ONDER_CDH1_SIGNALING_VIA_CTNNB1 ONDER_CDH1_SIGNALING_VIA_CTNNB1	-0.458	-0.958	0.301	-1.336	0.451	-0.672	-3.485	-1.836	1.726	2.468	2.898
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	0.389	1.559	0.783	1.135	-0.536	-5.372	0.633	1.135	1.338	-2.333	-2.320
HOLLERN_EMT_BREAST_TUMOR_DN HOLLERN_EMT_BREAST_TUMOR_DN	0.515	-1.928	-0.661	-1.508	-1.928	-0.343	-0.343	-0.661	-0.661	2.901	6.048
HINATA_NFKB_TARGETS_KERATINOCYTE_UP HINATA_NFKB_TARGETS_KERATINOCYTE_UP	-0.981	-0.981	-1.868	-2.547	0.615	-0.981	-0.981	0.435	0.615	4.755	2.427
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	1.180	3.588	1.565	0.571	-0.451	-1.990	-0.755	-0.755	0.351	-1.990	-1.984
LINDSTEDT_DENDRITIC_CELL_MATURATION_B LINDSTEDT_DENDRITIC_CELL_MATURATION_B	-2.031	-0.472	-0.472	-1.259	-1.259	-1.259	-0.271	1.137	1.137	6.149	-0.469
LIAN_LIPA_TARGETS_3M LIAN_LIPA_TARGETS_3M	0.440	-1.211	-1.783	-2.654	-0.810	0.274	-1.211	-0.527	1.546	3.302	2.359
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	-0.527	0.906	1.546	0.274	0.274	-2.654	-2.654	3.832	-0.329	0.274	-1.777
MILI_PSEUDOPODIA_CHEMOTAXIS_UP MILI_PSEUDOPODIA_CHEMOTAXIS_UP	-2.584	-1.005	0.806	1.331	-1.901	-3.568	0.806	1.988	1.331	0.419	-0.323
MIKKELSEN_IPS_WITH_HCP_H3K27ME3 MIKKELSEN_IPS_WITH_HCP_H3K27ME3	-0.270	0.334	-1.434	-1.888	0.849	5.389	-0.398	-2.466	-0.398	-1.434	1.956
VILIMAS_NOTCH1_TARGETS_UP VILIMAS_NOTCH1_TARGETS_UP	-1.328	-2.114	-0.837	0.301	-0.301	-0.301	-0.513	-0.513	-1.328	2.270	5.885
RICKMAN_HEAD_AND_NECK_CANCER_A RICKMAN_HEAD_AND_NECK_CANCER_A	0.461	-0.411	-2.500	-1.918	-0.280	3.413	0.323	-3.258	-0.411	0.629	2.621
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	-0.458	-1.836	0.636	0.636	-1.836	-3.485	1.726	2.081	2.081	-0.672	-0.667
RASHI_RESPONSE_TO_IONIZING_RADIATION_2 RASHI_RESPONSE_TO_IONIZING_RADIATION_2	-0.963	-2.043	-0.273	-0.388	-1.609	-3.227	-0.273	2.368	-0.273	3.080	2.057
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	-0.975	-1.221	-1.852	-2.715	1.140	0.364	-0.594	-0.975	0.364	3.376	3.756
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	-0.451	-2.009	-1.540	-2.009	0.576	0.290	-2.603	0.290	1.789	3.240	1.799
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	-2.745	-0.464	1.560	-0.347	-1.241	-2.745	0.754	2.670	2.078	0.754	-1.866
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	-0.775	2.096	1.087	2.501	-0.523	-3.153	0.412	0.412	-0.341	-0.523	-3.144
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	-0.817	-1.682	-2.089	-1.340	-0.465	2.960	-0.623	-0.623	0.265	0.643	5.423
MISSIAGLIA_REGULATED_BY_METHYLATION_DN MISSIAGLIA_REGULATED_BY_METHYLATION_DN	-0.905	0.254	0.364	2.496	-1.186	-3.122	-0.496	1.300	2.496	0.661	-3.110
IKEDA_MIR30_TARGETS_UP IKEDA_MIR30_TARGETS_UP	-3.714	0.439	0.311	-0.291	-0.291	-2.913	-0.291	3.559	1.765	0.775	-1.375
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	-0.580	-0.996	-0.996	-0.580	-1.608	-0.996	-0.996	-0.767	1.074	6.581	2.116
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	-0.490	2.224	1.656	0.964	-1.731	-3.940	0.469	0.964	0.348	0.348	-3.213
CROMER_TUMORIGENESIS_UP CROMER_TUMORIGENESIS_UP	-1.035	-1.571	-1.035	-1.035	0.362	-0.247	-0.668	-1.571	0.362	2.275	5.682
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	-0.981	-0.981	-0.313	0.831	-1.868	-1.868	3.267	3.736	0.615	-1.364	-0.687
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	-2.473	0.657	0.313	0.883	-0.934	-3.444	0.657	1.439	2.946	-0.442	-1.302
TIEN_INTESTINE_PROBIOTICS_6HR_DN TIEN_INTESTINE_PROBIOTICS_6HR_DN	-2.386	-0.510	-0.510	0.690	-0.662	-4.073	0.423	2.227	2.520	1.695	-1.055
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN	0.617	1.803	3.283	0.372	-0.327	-6.007	-0.926	0.276	0.485	-1.155	-0.564
GERY_CEBP_TARGETS GERY_CEBP_TARGETS	-1.084	-0.461	-0.831	0.384	-1.766	-1.766	-1.392	-0.461	1.067	5.764	1.841
ROSS_AML_WITH_MLL_FUSIONS ROSS_AML_WITH_MLL_FUSIONS	-0.865	0.724	0.353	0.353	-0.865	-3.319	-0.865	-0.596	2.282	4.109	-1.219
LIAN_LIPA_TARGETS_6M LIAN_LIPA_TARGETS_6M	-0.255	-0.596	-2.363	-3.319	-0.596	-0.397	-0.397	-0.397	1.243	3.608	1.911
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	-0.327	0.751	-0.327	0.370	-1.659	-6.441	0.914	1.094	0.914	1.992	-1.105
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2 ANDERSEN_CHOLANGIOCARCINOMA_CLASS2	-1.424	-3.580	-2.101	0.372	-0.436	1.333	-0.732	-0.732	1.333	1.803	2.971
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	-0.538	-1.477	2.214	0.376	-2.696	-2.696	-0.364	1.856	2.602	-0.538	0.248
VANTVEER_BREAST_CANCER_METASTASIS_DN VANTVEER_BREAST_CANCER_METASTASIS_DN	-1.214	-0.334	0.392	0.928	-2.671	-2.671	-0.334	0.542	3.982	1.715	-1.207
ZHANG_RESPONSE_TO_CANTHARIDIN_DN ZHANG_RESPONSE_TO_CANTHARIDIN_DN	1.416	3.079	0.818	1.776	-1.302	-2.779	-0.374	-1.302	0.238	-0.885	-1.296
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	-0.272	1.821	5.288	-0.704	-0.704	-0.704	-0.704	-0.704	-0.704	0.332	-0.702
SEIDEN_ONCOGENESIS_BY_MET SEIDEN_ONCOGENESIS_BY_MET	-1.999	-0.538	1.528	0.376	0.539	-2.696	1.231	2.602	0.736	-0.771	-2.686
WHITEFORD_PEDIATRIC_CANCER_MARKERS WHITEFORD_PEDIATRIC_CANCER_MARKERS	-1.408	-0.301	2.037	1.447	-1.815	-2.947	-0.301	0.959	2.724	-0.301	-1.806
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	-0.264	-1.654	0.692	-0.739	-0.739	-3.236	0.559	0.559	5.814	0.842	-1.363
PRAMOONJAGO_SOX4_TARGETS_UP PRAMOONJAGO_SOX4_TARGETS_UP	-1.397	0.272	-0.556	0.455	-1.397	-1.397	-1.397	-0.893	2.139	4.932	0.458
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	-0.556	-0.893	0.455	-0.332	-0.893	-2.197	-0.893	2.616	4.295	0.455	-1.392
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	-0.283	-0.940	-1.209	-2.395	1.379	2.536	-0.719	-1.209	-1.535	0.745	3.640
CROONQUIST_NRAS_SIGNALING_DN CROONQUIST_NRAS_SIGNALING_DN	-1.393	-0.647	1.636	0.519	-0.422	-2.903	-0.422	3.867	0.342	0.737	-1.992
ZHAN_MULTIPLE_MYELOMA_PR_UP ZHAN_MULTIPLE_MYELOMA_PR_UP	-1.907	-0.702	0.389	0.625	-0.702	-1.907	-0.702	3.193	3.193	-0.411	-0.699
ONDER_CDH1_TARGETS_3_DN ONDER_CDH1_TARGETS_3_DN	-0.691	-0.691	-1.606	-1.606	0.541	0.346	-0.260	0.346	-2.446	1.791	4.305
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	-0.338	-0.731	-0.731	-1.933	0.267	-3.610	-0.338	0.267	1.604	0.782	4.096
BASSO_B_LYMPHOCYTE_NETWORK BASSO_B_LYMPHOCYTE_NETWORK	0.597	2.498	1.626	0.457	-0.869	-4.871	-0.667	-0.503	0.943	0.597	-2.161
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	-1.160	-1.160	-1.160	1.962	-0.580	-1.160	-0.280	3.971	-0.280	0.978	-0.577
MIKKELSEN_MEF_LCP_WITH_H3K27ME3 MIKKELSEN_MEF_LCP_WITH_H3K27ME3	0.328	-2.035	-0.986	-2.035	0.328	4.323	-0.438	-2.035	0.966	0.328	1.266
JOHNSTONE_PARVB_TARGETS_2_UP JOHNSTONE_PARVB_TARGETS_2_UP	-0.851	-1.093	-0.360	0.348	-2.145	-3.940	0.469	1.173	2.224	2.872	-0.255
BURTON_ADIPOGENESIS_8 BURTON_ADIPOGENESIS_8	-1.198	-1.198	-0.577	0.367	-0.842	-3.277	-0.383	2.335	3.681	0.748	-0.242
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	-2.446	-0.434	-0.434	0.784	0.541	-2.446	0.346	1.411	3.177	-0.260	-1.601
CHEBOTAEV_GR_TARGETS_UP CHEBOTAEV_GR_TARGETS_UP	0.381	-1.643	-0.369	-2.290	-0.369	-0.369	-1.643	-1.171	1.638	3.755	1.646
BURTON_ADIPOGENESIS_3 BURTON_ADIPOGENESIS_3	-1.407	-0.385	-0.553	0.667	-0.553	-3.183	0.492	1.108	2.334	2.334	-2.423
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	3.806	3.000	0.545	-0.456	-0.629	-0.322	-0.322	-1.872	-3.017	-1.120	0.284
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	1.577	2.092	2.092	-0.385	-1.367	-1.367	0.453	0.231	-1.367	-0.733	-1.364
TIEN_INTESTINE_PROBIOTICS_6HR_UP TIEN_INTESTINE_PROBIOTICS_6HR_UP	-0.348	2.543	1.652	0.258	-1.431	-2.239	1.274	0.664	-0.921	-0.348	-2.233
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	0.251	0.511	2.284	1.951	-0.357	-3.523	-0.357	1.951	-0.703	-1.261	-2.123
HOELZEL_NF1_TARGETS_UP HOELZEL_NF1_TARGETS_UP	0.403	-1.274	-2.007	-0.430	-1.608	-0.580	-0.767	-0.580	0.693	1.545	6.109
GROSS_HYPOXIA_VIA_HIF1A_UP GROSS_HYPOXIA_VIA_HIF1A_UP	-0.355	5.483	0.798	1.350	-0.797	-2.253	-0.797	0.578	-1.144	-0.797	-1.139
ALCALA_APOPTOSIS ALCALA_APOPTOSIS	-0.338	0.576	1.943	5.126	-1.420	-2.621	-0.505	-0.338	-0.338	-0.505	-1.413
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	-1.053	0.557	0.995	0.995	-1.053	-2.658	-1.053	1.899	1.899	0.557	-2.649
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	0.233	0.612	-0.977	-0.382	-1.501	-2.322	-0.622	-0.977	0.877	5.239	0.615
BURTON_ADIPOGENESIS_6 BURTON_ADIPOGENESIS_6	0.405	3.871	1.792	1.559	-1.508	-1.508	-3.032	-0.647	-0.294	-1.011	0.313
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	-0.614	3.537	-0.266	1.516	-1.739	-3.360	0.701	0.701	-0.412	-0.266	-1.247
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	-0.893	-1.397	-0.893	-0.332	0.455	-2.197	0.272	1.706	3.695	0.980	-1.392
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	-1.093	-0.490	-1.731	-2.145	-0.490	-0.258	-0.851	0.348	0.348	5.729	1.942
RODRIGUES_DCC_TARGETS_DN RODRIGUES_DCC_TARGETS_DN	-0.469	-0.866	0.388	0.891	-1.142	-3.052	-1.142	1.111	2.585	2.585	-1.474
LIEN_BREAST_CARCINOMA_METAPLASTIC LIEN_BREAST_CARCINOMA_METAPLASTIC	-1.367	-0.733	-1.367	-0.733	0.453	0.754	-0.733	-1.367	0.231	3.306	2.098
KANG_DOXORUBICIN_RESISTANCE_UP KANG_DOXORUBICIN_RESISTANCE_UP	-1.431	-1.431	0.435	0.944	-0.578	-2.239	-0.348	3.053	1.652	0.664	-1.426
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	-0.285	-1.976	-1.321	-0.385	-0.510	-0.385	-1.623	-1.063	0.690	2.830	4.657
LENAOUR_DENDRITIC_CELL_MATURATION_DN LENAOUR_DENDRITIC_CELL_MATURATION_DN	-1.084	0.273	-1.392	0.384	-0.331	-2.218	-1.392	-0.831	4.819	2.130	0.683
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	-0.406	-1.363	-1.363	-2.862	0.357	1.029	0.539	-0.935	-0.626	2.065	2.951
KARLSSON_TGFB1_TARGETS_DN KARLSSON_TGFB1_TARGETS_DN	-1.549	-1.045	0.926	-0.408	-1.278	-3.623	0.496	1.983	2.521	1.510	-0.666
TAKAO_RESPONSE_TO_UVB_RADIATION_UP TAKAO_RESPONSE_TO_UVB_RADIATION_UP	-0.338	2.312	4.080	0.404	-1.933	-2.621	-0.505	-0.338	0.267	0.267	-1.413
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	1.104	-0.528	-1.278	-0.844	-0.310	-2.217	-0.310	-2.624	0.496	2.521	3.465
KAUFFMANN_MELANOMA_RELAPSE_UP KAUFFMANN_MELANOMA_RELAPSE_UP	-0.738	-0.738	0.315	1.689	-0.738	-2.529	0.728	1.325	2.094	-0.287	-2.522
DELPUECH_FOXO3_TARGETS_UP DELPUECH_FOXO3_TARGETS_UP	-0.835	-1.241	-0.546	-1.241	-0.835	-1.241	-1.241	1.168	1.876	4.302	0.631
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	-0.712	-0.402	-0.921	0.554	-0.921	-2.759	0.310	-0.541	-0.402	6.899	0.714
VALK_AML_CLUSTER_5 VALK_AML_CLUSTER_5	-0.702	-1.326	-0.702	0.480	-1.326	-1.326	-0.702	1.184	0.793	4.139	0.248
LIANG_SILENCED_BY_METHYLATION_2 LIANG_SILENCED_BY_METHYLATION_2	-1.606	-0.691	-2.446	-0.434	0.541	-0.434	-0.434	-0.434	-0.434	2.213	4.305
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	-0.595	0.901	2.566	-0.595	0.462	-4.315	-1.466	2.002	1.085	-0.761	-0.754
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	-1.055	0.311	1.765	2.076	-1.055	-2.913	-0.582	0.775	2.412	-0.582	-1.779
WELCSH_BRCA1_TARGETS_UP WELCSH_BRCA1_TARGETS_UP	-1.130	-0.919	2.356	0.842	-1.975	-2.760	-0.586	1.843	1.193	1.393	-1.120
ISHIDA_E2F_TARGETS ISHIDA_E2F_TARGETS	-0.865	-0.865	0.286	-0.316	-0.865	-2.156	1.761	1.017	2.203	1.017	-2.150
JAIN_NFKB_SIGNALING JAIN_NFKB_SIGNALING	0.288	2.619	1.153	1.466	-0.488	-3.070	-0.732	-0.732	0.878	-0.488	-2.136
SWEET_KRAS_TARGETS_UP SWEET_KRAS_TARGETS_UP	-0.289	-0.652	-1.803	-0.934	-0.289	-1.308	-1.803	-0.442	1.768	3.399	2.140
SABATES_COLORECTAL_ADENOMA_UP SABATES_COLORECTAL_ADENOMA_UP	-2.485	-0.996	-1.608	-1.274	0.872	1.298	-0.430	-1.274	0.536	2.103	2.761
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	-0.914	-0.442	-0.442	-0.728	-1.386	-3.376	-0.572	0.468	1.074	2.226	3.812
NAGASHIMA_NRG1_SIGNALING_UP NAGASHIMA_NRG1_SIGNALING_UP	-1.382	-0.704	-0.415	0.509	-2.051	-2.051	-0.704	1.169	0.509	5.288	0.652
DITTMER_PTHLH_TARGETS_UP DITTMER_PTHLH_TARGETS_UP	-1.310	0.481	0.481	1.875	-0.992	-3.599	-0.738	3.316	0.344	0.645	-0.985
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	-0.714	-0.898	-0.898	-1.367	0.277	-1.659	-0.327	-1.114	0.751	4.574	2.860
WHITFIELD_CELL_CYCLE_LITERATURE WHITFIELD_CELL_CYCLE_LITERATURE	-0.650	-1.090	2.277	0.239	-0.650	-1.824	0.239	0.239	3.385	0.430	-1.819
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	-0.581	-0.328	-0.581	-0.581	-1.490	-2.686	-0.441	-0.441	0.630	5.842	1.390
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	-1.580	-0.341	-0.523	1.387	1.087	-3.153	-0.523	1.724	1.724	0.265	-1.574
SMITH_TERT_TARGETS_UP SMITH_TERT_TARGETS_UP	-0.490	-0.652	1.404	0.777	-1.731	-3.940	0.777	1.930	1.173	0.469	-1.721
ZHU_CMV_8_HR_UP ZHU_CMV_8_HR_UP	0.501	-0.991	-1.699	-0.991	-0.991	-0.318	-1.699	0.501	1.534	3.082	0.787
FISCHER_G1_S_CELL_CYCLE FISCHER_G1_S_CELL_CYCLE	-1.130	-0.458	0.559	0.842	-2.760	-2.760	-0.586	1.843	3.242	0.692	-0.452
KARLSSON_TGFB1_TARGETS_UP KARLSSON_TGFB1_TARGETS_UP	0.828	3.577	0.644	1.037	-2.509	-2.509	-0.510	-0.366	-0.510	0.828	-1.550
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	0.870	0.262	-1.508	-1.508	0.515	0.376	-1.508	-1.508	-1.164	2.540	3.301
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2 BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	-0.422	4.988	2.012	0.997	-0.961	-1.393	-0.647	-0.647	-0.647	-1.393	-0.643
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	-0.489	-0.301	-0.762	-0.762	-0.489	-1.152	-1.152	-1.712	0.970	4.590	2.046
REN_BOUND_BY_E2F REN_BOUND_BY_E2F	-1.712	-0.489	2.474	1.284	-0.762	-2.571	0.701	0.970	0.701	-0.301	-1.706
KIM_WT1_TARGETS_8HR_UP KIM_WT1_TARGETS_8HR_UP	0.345	-1.901	-0.475	-0.356	-1.010	-3.323	0.345	2.046	2.046	2.330	-0.791
GENTILE_RESPONSE_CLUSTER_D3 GENTILE_RESPONSE_CLUSTER_D3	-0.893	0.272	0.980	1.319	-0.332	-2.197	-0.893	2.616	1.319	-1.397	-1.392
BROWN_MYELOID_CELL_DEVELOPMENT_DN BROWN_MYELOID_CELL_DEVELOPMENT_DN	3.362	1.410	0.945	-0.566	-0.566	-4.136	-1.003	-0.292	0.432	0.432	-1.292
GOZGIT_ESR1_TARGETS_UP GOZGIT_ESR1_TARGETS_UP	-0.712	-0.541	-0.292	-1.474	-0.712	-1.474	-0.712	-0.541	0.554	6.899	1.090
SONG_TARGETS_OF_IE86_CMV_PROTEIN SONG_TARGETS_OF_IE86_CMV_PROTEIN	-0.949	-0.600	2.973	0.637	-0.600	-2.280	1.232	0.637	0.637	-0.365	-2.274
TIAN_TNF_SIGNALING_VIA_NFKB TIAN_TNF_SIGNALING_VIA_NFKB	-1.077	-1.077	-1.077	-0.241	-1.077	0.371	0.371	0.684	-1.077	3.507	1.092
BURTON_ADIPOGENESIS_PEAK_AT_0HR BURTON_ADIPOGENESIS_PEAK_AT_0HR	0.938	0.459	0.288	-0.508	-0.786	-1.748	-2.613	-0.508	-0.508	4.491	0.680
LAU_APOPTOSIS_CDKN2A_UP LAU_APOPTOSIS_CDKN2A_UP	-0.600	-1.466	1.601	0.910	-0.600	-2.280	-0.949	2.015	1.232	0.637	-1.461
PARK_TRETINOIN_RESPONSE PARK_TRETINOIN_RESPONSE	0.166	-0.497	-0.497	-0.497	-0.497	-0.497	-0.497	-0.497	1.052	5.787	-0.496
SMIRNOV_RESPONSE_TO_IR_6HR_UP SMIRNOV_RESPONSE_TO_IR_6HR_UP	-0.813	0.445	0.722	-0.486	-0.813	-5.731	-0.634	1.076	0.889	2.295	0.450
WONG_PROTEASOME_GENE_MODULE WONG_PROTEASOME_GENE_MODULE	0.521	1.877	0.781	-0.492	-0.285	-2.073	1.095	0.781	0.317	-2.073	-2.067
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	0.346	-0.691	-0.260	-1.606	-2.446	-1.064	-1.064	0.784	0.784	2.676	1.799
CERVERA_SDHB_TARGETS_1_UP CERVERA_SDHB_TARGETS_1_UP	0.254	-0.496	0.364	-1.957	-0.677	-1.957	0.364	-1.533	0.254	2.853	3.650
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2 SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	-1.261	-1.901	0.457	-0.356	-1.010	-3.323	0.345	0.738	1.781	2.951	0.745
KOBAYASHI_EGFR_SIGNALING_24HR_UP KOBAYASHI_EGFR_SIGNALING_24HR_UP	-0.553	-1.407	0.872	-1.858	-1.858	-1.407	-0.553	0.346	1.665	2.334	1.997
JIANG_HYPOXIA_CANCER JIANG_HYPOXIA_CANCER	-0.247	0.564	1.112	1.456	-0.416	-2.405	-0.247	0.362	1.844	-1.571	-2.398
CERVERA_SDHB_TARGETS_2 CERVERA_SDHB_TARGETS_2	0.322	-1.760	-1.760	-2.256	1.801	-1.034	-0.405	-0.567	2.116	1.801	1.014
PHONG_TNF_TARGETS_UP PHONG_TNF_TARGETS_UP	-1.748	-2.613	-0.508	-0.315	-0.786	-0.786	0.288	0.675	0.288	2.878	2.421
SUNG_METASTASIS_STROMA_DN SUNG_METASTASIS_STROMA_DN	-2.239	-0.921	1.274	2.076	0.258	-1.431	-2.239	0.664	0.664	0.664	0.260
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	-0.373	1.702	-0.250	-0.250	-1.381	-4.192	0.687	1.405	1.405	-0.250	-1.374
LENAOUR_DENDRITIC_CELL_MATURATION_UP LENAOUR_DENDRITIC_CELL_MATURATION_UP	2.076	-0.291	0.439	-0.582	-1.383	-0.792	-1.787	-1.787	-0.792	2.412	2.425
RIZ_ERYTHROID_DIFFERENTIATION RIZ_ERYTHROID_DIFFERENTIATION	-0.911	-0.911	0.484	1.176	-0.278	-3.402	0.484	3.008	0.484	0.484	-1.764
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	-0.464	0.468	0.260	2.992	-1.534	-2.745	1.330	1.560	0.601	-0.992	-1.866
GRABARCZYK_BCL11B_TARGETS_UP GRABARCZYK_BCL11B_TARGETS_UP	-1.739	0.339	1.516	-0.412	-0.888	-1.739	-0.412	0.937	1.516	2.230	-2.391
BOYLAN_MULTIPLE_MYELOMA_D_DN BOYLAN_MULTIPLE_MYELOMA_D_DN	-1.253	-0.614	0.339	0.502	-0.614	-3.360	-1.253	0.339	0.937	3.071	1.216
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	0.577	0.577	-0.354	-0.468	-1.211	-3.677	-0.354	-1.487	0.344	1.482	3.869
HAHTOLA_SEZARY_SYNDROM_UP HAHTOLA_SEZARY_SYNDROM_UP	-2.331	0.728	0.384	-0.348	-2.331	-1.768	0.384	0.259	0.540	4.188	0.388
DAZARD_RESPONSE_TO_UV_SCC_DN DAZARD_RESPONSE_TO_UV_SCC_DN	-0.774	-0.405	0.452	1.246	-1.034	-4.775	-0.281	2.116	1.246	0.452	-0.562
LUCAS_HNF4A_TARGETS_UP LUCAS_HNF4A_TARGETS_UP	-1.571	0.362	-0.416	1.456	0.362	-2.405	-0.668	-0.416	-0.247	4.391	-0.664
RODRIGUES_THYROID_CARCINOMA_DN RODRIGUES_THYROID_CARCINOMA_DN	-1.643	0.381	-0.369	0.243	-1.171	-3.236	-0.820	0.772	1.997	1.638	1.031
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	-0.961	-0.961	-1.393	1.297	-0.264	-2.903	1.636	0.519	1.636	0.997	-0.956
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	0.806	-0.326	-2.584	-3.568	0.595	1.644	0.595	-1.005	-0.326	0.806	0.812
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	-0.981	-0.691	0.615	-0.691	-0.691	-3.527	-0.473	0.435	2.826	2.034	0.438
MALONEY_RESPONSE_TO_17AAG_DN MALONEY_RESPONSE_TO_17AAG_DN	1.350	1.055	2.444	1.350	-1.144	-1.612	-0.355	0.253	-0.355	-1.612	-2.245
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	-2.197	3.135	0.980	0.980	0.691	-0.893	-1.397	-0.893	0.691	-0.556	-0.888
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	0.250	1.458	2.231	1.132	0.405	-1.855	-1.271	0.604	-0.566	-0.566	-2.729
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	-0.814	-2.167	-0.647	0.797	-0.389	-4.170	1.792	1.343	1.343	0.309	0.656
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	0.551	-1.010	-1.249	-0.278	-0.806	-1.854	-1.010	-1.010	1.912	3.755	1.444
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	-1.036	-1.036	1.149	1.658	0.398	-1.036	-0.491	1.658	0.726	-1.036	-1.033
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	1.438	1.164	1.164	2.429	-1.006	-3.107	-0.733	0.249	-1.006	-1.355	0.251
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	-0.468	0.344	-0.262	-1.807	-0.354	-1.807	-0.354	-0.608	-0.468	0.577	6.777
RICKMAN_HEAD_AND_NECK_CANCER_E RICKMAN_HEAD_AND_NECK_CANCER_E	-0.505	-1.029	-1.933	-1.420	0.782	3.596	0.404	-1.420	-0.731	1.297	1.030
GHANDHI_DIRECT_IRRADIATION_UP GHANDHI_DIRECT_IRRADIATION_UP	-0.829	-0.601	-1.949	-0.601	-0.829	-0.291	0.447	-0.829	-0.601	3.789	3.370
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	-2.495	-0.426	0.382	-0.426	-1.136	-2.982	0.632	1.148	2.677	1.585	-0.315
LAIHO_COLORECTAL_CANCER_SERRATED_DN LAIHO_COLORECTAL_CANCER_SERRATED_DN	-0.711	3.203	-0.326	0.278	-0.711	-2.584	1.331	0.419	0.806	0.278	-2.575
PEART_HDAC_PROLIFERATION_CLUSTER_DN PEART_HDAC_PROLIFERATION_CLUSTER_DN	0.328	-0.438	-0.438	2.366	-0.986	-2.945	0.966	1.592	0.328	0.328	-2.028
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	-0.556	-0.722	-0.420	-0.556	0.292	-1.779	-1.779	-0.722	0.660	1.671	5.113
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	-0.940	1.184	-0.319	0.985	-1.468	-3.833	-0.568	2.178	0.985	0.985	-0.932
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	-1.003	0.945	-0.292	0.578	-0.566	-5.275	1.410	1.166	0.578	0.432	-0.755
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	0.664	1.652	1.652	1.652	-0.921	-1.431	0.258	0.258	-0.578	-1.431	-2.233
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3 MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	-1.077	-1.077	-0.241	-0.241	3.507	1.578	-1.077	-1.077	0.371	-0.520	0.373
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	-0.599	-0.599	-1.024	-1.024	0.476	2.987	-0.336	-1.024	-1.741	1.477	1.483
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	-0.448	-0.610	0.533	0.282	-0.610	-3.404	-1.369	0.881	0.695	4.437	-0.444
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	-1.064	-0.732	-0.732	0.288	-1.064	-3.070	0.288	0.642	1.815	2.619	0.646
VERNELL_RETINOBLASTOMA_PATHWAY_UP VERNELL_RETINOBLASTOMA_PATHWAY_UP	-0.961	-1.999	0.342	0.737	-0.422	-1.999	-0.264	2.012	0.737	2.425	-1.387
TIEN_INTESTINE_PROBIOTICS_2HR_DN TIEN_INTESTINE_PROBIOTICS_2HR_DN	-1.477	-1.077	0.246	0.539	-0.538	-2.696	0.376	0.967	3.018	1.528	-1.072
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	-2.734	-0.610	-0.321	2.168	-2.734	-1.063	0.881	1.583	0.881	0.533	-0.318
ROSS_AML_WITH_PML_RARA_FUSION ROSS_AML_WITH_PML_RARA_FUSION	-2.400	0.937	0.937	-0.412	-0.412	-2.400	-1.253	-0.614	0.937	2.230	0.943
FARMER_BREAST_CANCER_CLUSTER_2 FARMER_BREAST_CANCER_CLUSTER_2	-0.385	-1.367	1.130	-0.385	0.231	-1.367	0.231	1.577	2.669	-0.733	-1.364
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	1.330	1.330	0.754	0.260	-1.877	-2.745	0.260	2.992	-0.464	-0.782	-1.232
AMIT_EGF_RESPONSE_480_HELA AMIT_EGF_RESPONSE_480_HELA	0.492	0.276	0.630	0.787	-1.490	-4.632	-1.828	0.787	1.162	0.965	0.636
JI_RESPONSE_TO_FSH_DN JI_RESPONSE_TO_FSH_DN	-0.893	0.980	-0.332	-0.332	-0.893	-2.197	-0.893	0.980	3.695	0.691	-0.888
DE_YY1_TARGETS_DN DE_YY1_TARGETS_DN	-2.131	-1.592	0.472	-0.279	-0.606	-2.131	2.395	-0.279	2.029	1.109	-0.276
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	-0.961	-1.999	-0.647	0.342	-0.264	-1.999	-0.961	0.342	2.012	2.012	1.644
HUTTMANN_B_CLL_POOR_SURVIVAL_DN HUTTMANN_B_CLL_POOR_SURVIVAL_DN	-1.606	-1.064	0.346	-0.260	0.346	-2.446	-0.691	-0.260	2.213	2.676	0.348
NGUYEN_NOTCH1_TARGETS_UP NGUYEN_NOTCH1_TARGETS_UP	-0.260	-0.260	-1.119	-0.260	-0.260	-1.119	-0.550	-0.260	4.949	1.032	-1.116
WENDT_COHESIN_TARGETS_UP WENDT_COHESIN_TARGETS_UP	-1.326	-0.702	-1.326	0.247	0.480	-1.326	0.247	4.139	0.793	-0.363	0.248
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	-0.432	-0.875	-0.432	-1.621	-0.432	-0.624	-1.621	-0.290	0.456	5.072	1.663
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	-1.367	0.231	0.453	-0.733	-0.733	-1.367	2.669	0.453	1.577	0.453	-1.364
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	-0.473	0.372	1.271	1.796	0.264	-3.475	-1.104	0.372	-0.641	2.411	-1.407
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	-0.647	0.737	0.997	1.297	0.342	-2.903	-0.961	0.997	1.297	-1.999	-0.643
EPPERT_LSC_R EPPERT_LSC_R	-0.599	1.928	0.749	1.477	-1.024	-1.024	-1.741	0.269	1.083	0.269	-1.736
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	-1.855	-0.566	2.231	-0.566	-1.271	-0.860	0.405	-1.855	1.132	1.132	1.466
KASLER_HDAC7_TARGETS_1_UP KASLER_HDAC7_TARGETS_1_UP	-0.621	0.998	2.102	1.610	-0.621	-4.806	-0.484	0.425	0.677	-0.371	-0.970
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	-0.893	-0.893	0.455	-0.332	-0.893	-2.197	0.980	2.139	2.616	-0.332	-0.888
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	-1.741	-1.741	0.269	3.591	-1.024	-1.024	0.476	0.269	0.476	0.476	0.479
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	0.712	1.259	1.592	0.499	-0.438	-2.945	0.499	0.712	-0.276	-1.424	-2.028
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	-0.411	0.827	0.461	2.998	-2.500	-1.918	-1.097	1.053	0.323	0.827	-1.091
ZHAN_MULTIPLE_MYELOMA_LB_UP ZHAN_MULTIPLE_MYELOMA_LB_UP	-0.242	-1.948	-0.729	0.883	-0.242	-1.948	-0.729	-0.431	1.620	0.370	2.570
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	-1.540	1.220	1.220	2.114	-0.869	-3.372	-0.634	0.290	0.576	0.762	-0.863
WHITFIELD_CELL_CYCLE_G1_S WHITFIELD_CELL_CYCLE_G1_S	-0.656	-0.486	1.021	2.056	-0.656	-3.511	-0.486	1.021	1.492	0.490	-1.809
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	0.245	0.245	0.416	0.416	-2.280	-2.280	1.232	2.015	0.416	0.416	-1.461
VANHARANTA_UTERINE_FIBROID_DN VANHARANTA_UTERINE_FIBROID_DN	-0.374	-0.885	-0.885	-0.885	0.238	-1.302	-0.885	0.818	1.096	5.293	-0.582
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP	0.595	-0.711	0.278	-1.005	-0.711	-1.005	-1.005	-1.901	0.806	4.155	1.339
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	0.404	-1.420	-0.731	-0.731	0.267	1.943	0.404	-3.610	0.576	0.267	1.953
TSAI_RESPONSE_TO_IONIZING_RADIATION TSAI_RESPONSE_TO_IONIZING_RADIATION	-2.790	-0.554	-0.728	1.511	-1.193	-1.193	0.301	-0.301	0.540	3.726	0.698
GEISS_RESPONSE_TO_DSRNA_UP GEISS_RESPONSE_TO_DSRNA_UP	-0.925	-0.525	0.320	-1.616	-0.283	-0.925	-0.925	1.226	-0.525	3.931	0.862
INGRAM_SHH_TARGETS_UP INGRAM_SHH_TARGETS_UP	-0.282	-0.400	-1.277	-2.072	0.321	-0.983	-0.552	2.327	1.440	2.668	-1.269
SEKI_INFLAMMATORY_RESPONSE_LPS_UP SEKI_INFLAMMATORY_RESPONSE_LPS_UP	-0.577	-1.198	-1.198	-1.198	0.367	-1.198	-0.383	-0.383	0.748	1.277	4.742
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP	0.720	-0.865	0.476	-2.156	-0.865	-2.156	0.476	0.476	-0.316	2.203	1.022
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	-1.113	0.759	-1.756	1.377	0.457	-3.977	0.759	1.150	1.150	-0.267	-0.661
MIKKELSEN_ES_LCP_WITH_H3K4ME3 MIKKELSEN_ES_LCP_WITH_H3K4ME3	0.482	-1.362	-1.074	-0.834	-1.074	2.578	0.628	-1.362	-0.834	0.482	3.290
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	0.646	-0.453	-0.828	0.380	-1.492	-1.492	0.380	0.646	0.984	2.389	-1.488
LIM_MAMMARY_LUMINAL_MATURE_DN LIM_MAMMARY_LUMINAL_MATURE_DN	0.816	-1.650	-0.447	-1.650	-0.897	-0.447	-0.301	-0.897	0.301	1.318	4.496
MIKKELSEN_IPS_ICP_WITH_H3K27ME3 MIKKELSEN_IPS_ICP_WITH_H3K27ME3	1.232	0.245	-2.280	-2.280	-0.600	1.232	0.416	-0.949	0.245	0.416	1.608
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6 MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	-1.948	0.597	0.597	-0.242	-0.729	-1.948	-0.431	0.370	3.102	0.883	-0.725
WILENSKY_RESPONSE_TO_DARAPLADIB WILENSKY_RESPONSE_TO_DARAPLADIB	0.324	-1.160	0.324	-0.580	-0.580	-1.160	-0.580	-0.280	-0.280	5.629	0.325
SIMBULAN_UV_RESPONSE_NORMAL_DN SIMBULAN_UV_RESPONSE_NORMAL_DN	0.453	-1.367	-0.385	0.754	-1.367	-1.367	-1.367	0.754	1.130	0.754	1.134
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	0.434	-0.580	4.008	0.892	-0.580	-0.580	0.434	-0.580	-0.580	-0.580	-0.578
AKL_HTLV1_INFECTION_DN AKL_HTLV1_INFECTION_DN	-1.963	-1.363	-0.935	0.357	0.357	-0.935	-0.406	-0.406	0.357	3.950	1.689
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	-1.308	-0.652	-0.652	-0.289	0.467	-2.473	-0.934	0.657	1.768	3.399	-0.287
DIRMEIER_LMP1_RESPONSE_EARLY DIRMEIER_LMP1_RESPONSE_EARLY	-0.762	0.301	1.284	-0.301	-2.571	-1.712	-0.762	1.284	-0.489	2.037	0.705
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	-0.566	0.846	1.132	1.825	1.132	-2.737	-0.860	0.846	-0.566	-1.271	-0.855
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	-1.580	0.412	-0.341	0.824	-1.117	-3.153	0.265	0.412	2.501	1.087	-0.338
COLLER_MYC_TARGETS_UP COLLER_MYC_TARGETS_UP	3.048	2.357	0.426	-0.204	-0.462	-0.994	-0.994	-0.994	-0.462	-0.462	-0.460
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	0.259	-0.984	-0.714	0.259	-0.714	0.540	-0.714	-1.329	-0.714	0.540	6.306
REICHERT_MITOSIS_LIN9_TARGETS REICHERT_MITOSIS_LIN9_TARGETS	-1.119	-1.119	0.644	-0.260	0.347	-1.119	-1.119	0.644	2.675	1.032	-0.548
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	-0.267	1.377	-0.371	0.338	-0.667	-4.871	-0.267	-0.267	2.187	0.943	-0.862
WINZEN_DEGRADED_VIA_KHSRP WINZEN_DEGRADED_VIA_KHSRP	-1.355	-0.733	-1.798	-0.360	-1.006	1.164	-1.006	-0.521	0.707	2.813	2.082
PRAMOONJAGO_SOX4_TARGETS_DN PRAMOONJAGO_SOX4_TARGETS_DN	1.137	1.137	2.929	-0.472	-0.782	-0.782	-2.031	0.334	0.546	-1.259	-0.779
SMITH_LIVER_CANCER SMITH_LIVER_CANCER	-1.990	-0.451	1.180	0.848	-0.755	-1.225	0.351	0.848	0.848	1.180	-1.984
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	-1.160	2.564	1.432	0.607	-0.280	-1.160	0.324	-1.160	-0.280	0.324	-1.157
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	0.464	-0.687	-1.872	-1.167	-0.512	-1.167	-0.512	-0.265	0.464	5.012	1.203
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	-1.090	-1.090	-0.373	-1.824	-0.650	0.239	0.430	-0.373	0.239	4.009	1.376
RHODES_CANCER_META_SIGNATURE RHODES_CANCER_META_SIGNATURE	0.274	1.205	2.349	0.906	-0.329	-1.783	-1.211	1.205	-0.329	-1.211	-1.777
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	3.283	-0.327	0.768	-0.436	-2.523	-2.523	-0.926	-0.436	0.938	0.617	0.624
RUIZ_TNC_TARGETS_UP RUIZ_TNC_TARGETS_UP	-1.318	-1.636	-0.358	-0.482	-0.358	-2.012	-0.823	0.934	1.352	3.433	0.942
KAMMINGA_EZH2_TARGETS KAMMINGA_EZH2_TARGETS	-0.991	0.501	-0.574	1.997	-1.699	-0.991	0.501	0.501	1.534	0.501	-1.695
ABRAMSON_INTERACT_WITH_AIRE ABRAMSON_INTERACT_WITH_AIRE	-0.373	1.798	2.277	0.684	-0.373	-1.824	-1.090	-0.373	0.239	0.430	-1.819
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	-0.582	-0.582	0.311	-0.418	-1.383	-2.288	0.439	1.218	-0.418	4.905	-0.414
WAKASUGI_HAVE_ZNF143_BINDING_SITES WAKASUGI_HAVE_ZNF143_BINDING_SITES	0.258	-0.348	0.944	1.274	0.664	-2.239	0.258	0.944	0.664	-1.431	-2.233
LEE_LIVER_CANCER_DENA_UP LEE_LIVER_CANCER_DENA_UP	-1.093	-0.452	0.519	-1.093	-1.642	2.153	-1.093	0.330	-0.715	3.099	0.523
DER_IFN_BETA_RESPONSE_UP DER_IFN_BETA_RESPONSE_UP	-1.434	-0.569	-0.270	0.849	-0.398	-3.220	1.080	0.648	1.945	1.080	-1.426
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	1.021	1.763	-3.511	-2.276	0.255	-0.867	-0.352	1.245	0.255	0.361	0.827
YU_BAP1_TARGETS YU_BAP1_TARGETS	-0.300	-0.610	-0.300	0.302	-0.610	-1.202	-1.202	1.877	1.365	1.877	-1.198
RICKMAN_HEAD_AND_NECK_CANCER_D RICKMAN_HEAD_AND_NECK_CANCER_D	-0.893	-0.500	-0.500	-0.893	0.898	4.054	1.278	-1.575	-0.500	-0.500	-0.265
RUIZ_TNC_TARGETS_DN RUIZ_TNC_TARGETS_DN	0.369	-0.817	0.495	1.459	-1.340	-3.159	-1.340	2.298	1.222	0.369	-0.336
MOHANKUMAR_HOXA1_TARGETS_DN MOHANKUMAR_HOXA1_TARGETS_DN	0.301	-0.533	-0.689	-1.669	1.191	0.402	-2.440	-0.689	-0.405	0.818	4.161
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	-0.661	-1.164	0.262	-1.164	-0.661	-0.885	0.262	0.262	-0.343	6.550	0.519
NEWMAN_ERCC6_TARGETS_DN NEWMAN_ERCC6_TARGETS_DN	-0.925	-0.525	-0.925	-1.616	0.320	1.226	-0.525	-0.283	-0.283	-0.283	4.639
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	-0.329	-0.810	-0.527	-1.783	1.205	0.440	-1.211	-1.211	-0.329	0.906	3.845
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	-1.127	-0.812	-0.572	-0.812	-0.258	-0.572	-0.812	-1.534	2.119	2.496	2.130
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	-0.431	0.370	0.597	0.370	-1.948	-1.948	-0.242	1.620	2.066	-0.242	-1.187
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	-1.158	-1.158	-1.158	-0.411	-0.228	-0.702	-0.411	1.271	-0.702	1.271	3.803
KAUFFMANN_DNA_REPLICATION_GENES KAUFFMANN_DNA_REPLICATION_GENES	-0.515	-0.381	1.351	1.126	-0.515	-4.013	0.445	1.864	0.445	0.329	-1.771
SANA_TNF_SIGNALING_UP SANA_TNF_SIGNALING_UP	-0.458	-1.336	-1.836	0.301	0.451	-1.836	-0.672	0.301	0.451	2.468	2.480
HAN_JNK_SINGALING_UP HAN_JNK_SINGALING_UP	-0.430	-1.450	-0.219	-1.450	-0.796	-0.219	-0.796	0.403	1.030	3.740	0.405
BROWNE_HCMV_INFECTION_10HR_UP BROWNE_HCMV_INFECTION_10HR_UP	-1.739	-0.962	-0.336	-0.962	0.558	-1.739	1.507	-0.962	2.159	1.819	0.401
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	-1.907	0.389	0.625	0.389	0.389	-1.158	-0.702	0.389	2.640	0.625	-1.901
GOLDRATH_IMMUNE_MEMORY GOLDRATH_IMMUNE_MEMORY	0.440	-0.329	0.274	-0.810	-1.783	-2.654	-0.329	0.906	0.906	2.808	-0.327
GERHOLD_ADIPOGENESIS_DN GERHOLD_ADIPOGENESIS_DN	-0.489	0.301	0.970	-0.489	-1.152	-1.152	-2.571	-0.301	0.478	2.949	0.976
ODONNELL_TFRC_TARGETS_DN ODONNELL_TFRC_TARGETS_DN	-0.320	-0.320	0.283	-0.320	-1.296	-1.632	0.522	3.418	2.375	-0.784	-1.623
DOANE_RESPONSE_TO_ANDROGEN_UP DOANE_RESPONSE_TO_ANDROGEN_UP	-0.302	2.649	0.301	-1.308	-0.302	-2.746	-0.402	-1.062	2.357	0.968	-0.667
BRUECKNER_TARGETS_OF_MIRLET7A3_DN BRUECKNER_TARGETS_OF_MIRLET7A3_DN	-1.117	-0.523	-0.341	-0.523	-0.523	-0.523	-1.117	0.412	-1.117	2.096	4.454
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	-0.283	-0.283	-1.616	-1.616	1.226	-0.283	0.320	-0.525	-0.925	0.555	3.294
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	-0.746	-0.746	-0.298	-0.298	-0.746	-0.746	-0.298	-0.298	-0.298	2.399	3.190
LANDIS_ERBB2_BREAST_TUMORS_324_UP LANDIS_ERBB2_BREAST_TUMORS_324_UP	-2.312	-0.310	0.292	-0.567	-0.567	-2.312	-0.424	3.306	0.526	1.738	0.403
JIANG_TIP30_TARGETS_UP JIANG_TIP30_TARGETS_UP	-1.907	0.625	-0.228	-1.158	-0.228	-1.907	0.920	1.271	1.677	0.389	-0.699
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	0.551	-0.751	-0.418	-2.455	3.519	0.301	0.551	-1.252	-1.252	-0.301	1.585
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	-0.369	0.496	-0.971	-2.163	0.664	0.664	-2.163	-0.971	0.355	1.082	2.986
BASSO_CD40_SIGNALING_UP BASSO_CD40_SIGNALING_UP	-1.858	-1.051	-0.771	0.346	-0.385	-1.407	-0.260	0.492	0.667	4.953	0.350
BROWNE_HCMV_INFECTION_18HR_UP BROWNE_HCMV_INFECTION_18HR_UP	-1.100	-0.877	0.660	0.522	-0.405	-2.922	0.402	3.413	0.995	0.522	-1.352
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2 PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	-2.180	0.276	-0.327	-0.327	-1.549	-0.753	-0.753	-0.327	0.620	2.559	2.570
CHUNG_BLISTER_CYTOTOXICITY_UP CHUNG_BLISTER_CYTOTOXICITY_UP	-0.539	2.214	1.635	0.580	-1.209	-2.962	-0.719	1.144	-0.396	0.580	-1.201
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	-0.287	-0.470	-0.738	-0.287	1.689	-2.529	-0.470	-1.122	0.728	-0.287	3.035
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP	-0.434	4.846	0.457	0.199	0.199	-0.953	-0.434	-0.953	-0.434	0.457	-0.950
BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN	1.163	0.413	3.447	1.163	-0.829	-2.351	-0.613	-1.099	-1.099	0.413	-0.439
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	-0.958	-1.836	-1.336	-0.958	-0.301	0.451	-1.336	1.726	1.726	0.856	1.410
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	0.756	-1.318	-0.636	-1.048	-0.358	-0.823	0.463	-2.455	0.463	2.130	2.761
LEE_LIVER_CANCER_HEPATOBLAST LEE_LIVER_CANCER_HEPATOBLAST	-0.663	-0.663	-0.663	-0.663	-0.247	-0.247	-0.663	0.362	-0.247	4.517	0.764
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	-0.977	-0.977	0.233	-0.382	-0.622	-1.501	-0.977	-0.382	0.877	2.405	2.906
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	-0.366	-0.366	-0.813	-1.027	0.445	-4.004	-0.486	0.889	1.282	2.594	0.450
KOBAYASHI_EGFR_SIGNALING_6HR_DN KOBAYASHI_EGFR_SIGNALING_6HR_DN	-0.746	-0.298	-0.746	-0.298	-0.746	-0.746	-0.746	-0.298	1.713	1.713	1.717
WOO_LIVER_CANCER_RECURRENCE_UP WOO_LIVER_CANCER_RECURRENCE_UP	-0.829	0.312	0.447	-0.601	-0.424	-1.949	-1.120	-0.601	-0.291	1.279	4.746
PECE_MAMMARY_STEM_CELL_DN PECE_MAMMARY_STEM_CELL_DN	-0.851	-0.490	0.469	0.469	-0.652	-3.226	-0.490	2.224	2.224	0.777	-1.086
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	-0.355	0.798	0.578	1.350	-0.541	-1.612	-0.797	0.578	1.680	0.253	-3.185
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN	-0.755	-0.755	-1.225	0.351	-0.755	-1.990	0.351	0.571	2.485	2.001	-0.254
GENTILE_UV_RESPONSE_CLUSTER_D7 GENTILE_UV_RESPONSE_CLUSTER_D7	-0.860	1.332	3.503	-0.477	-0.860	-1.533	-0.250	0.940	-0.860	-0.250	-0.474
ZAMORA_NOS2_TARGETS_UP ZAMORA_NOS2_TARGETS_UP	-1.501	0.233	2.895	0.612	-0.977	-0.622	-0.977	2.405	-0.622	0.397	-0.973
MISSIAGLIA_REGULATED_BY_METHYLATION_UP MISSIAGLIA_REGULATED_BY_METHYLATION_UP	-0.744	-0.552	-2.072	0.321	-0.744	-2.072	0.445	0.321	1.440	3.415	0.599
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD	-0.828	-0.828	-0.828	-0.351	2.866	-0.351	-0.828	0.256	-0.351	0.256	2.154
JIANG_HYPOXIA_NORMAL JIANG_HYPOXIA_NORMAL	0.341	-0.351	1.193	1.193	-0.586	-5.971	0.341	0.442	0.442	0.692	-0.452
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	0.614	1.620	2.164	0.614	-1.297	-1.297	-2.426	-0.348	1.155	-1.297	-0.344
ANDERSEN_LIVER_CANCER_KRT19_UP ANDERSEN_LIVER_CANCER_KRT19_UP	-0.765	3.191	0.216	1.512	-0.765	-0.765	-0.765	-0.765	0.427	0.716	-1.405
SESTO_RESPONSE_TO_UV_C8 SESTO_RESPONSE_TO_UV_C8	0.328	-0.668	0.966	-0.438	-0.986	-2.945	-1.424	0.712	0.499	1.259	1.600
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	0.291	-0.829	0.291	-0.312	-0.312	-2.982	-0.829	0.413	0.561	4.765	-0.439
GEORGES_CELL_CYCLE_MIR192_TARGETS GEORGES_CELL_CYCLE_MIR192_TARGETS	-1.712	-1.712	0.301	0.970	-0.489	-1.712	0.478	0.970	2.037	0.970	-0.758
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	0.737	0.519	1.297	0.737	-0.961	-1.393	-0.961	1.297	1.297	-1.999	-1.387
FARMER_BREAST_CANCER_CLUSTER_4 FARMER_BREAST_CANCER_CLUSTER_4	-0.324	-0.787	1.057	-0.787	0.609	-0.324	-0.787	-0.787	-0.324	-0.324	3.865
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	-0.753	-1.091	-0.327	-3.111	-0.506	0.276	-0.506	0.428	1.119	1.769	1.778
SMIRNOV_RESPONSE_TO_IR_6HR_DN SMIRNOV_RESPONSE_TO_IR_6HR_DN	-0.552	-0.393	1.274	-0.272	-0.272	-4.734	-0.552	0.333	1.837	0.333	0.633
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	0.254	0.254	-1.057	-1.057	0.715	1.423	-1.782	-0.624	-1.057	0.715	2.362
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	-0.406	2.484	1.681	0.539	-0.626	-1.363	0.539	-1.363	-0.626	0.763	-1.956
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	0.359	0.940	-0.860	-0.860	-1.533	-0.860	-0.860	1.332	0.359	-0.477	2.885
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	-0.552	-0.744	-0.744	-1.277	1.191	2.668	-0.552	-0.983	-0.983	-0.400	3.046
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	-0.939	1.059	1.275	1.511	-0.728	-3.393	0.864	0.410	0.410	0.301	-1.847
NAKAJIMA_MAST_CELL NAKAJIMA_MAST_CELL	-0.411	-0.702	-0.702	-0.411	1.271	-1.158	-0.702	-0.702	-0.702	0.920	4.446
ELVIDGE_HYPOXIA_UP ELVIDGE_HYPOXIA_UP	-0.676	0.675	-0.395	-0.676	-2.001	-1.341	-1.081	-0.395	1.431	3.457	1.024
MARZEC_IL2_SIGNALING_DN MARZEC_IL2_SIGNALING_DN	-0.828	-0.828	0.380	0.984	-0.453	-1.492	-0.453	-0.828	3.619	-0.453	0.988
DURAND_STROMA_NS_UP DURAND_STROMA_NS_UP	-0.356	-0.621	-0.621	0.738	-2.304	-1.261	-0.621	-1.010	1.534	1.781	2.345
WIERENGA_STAT5A_TARGETS_GROUP2 WIERENGA_STAT5A_TARGETS_GROUP2	-0.921	-0.348	-2.239	-0.921	0.258	-0.578	-0.348	-0.348	1.652	3.053	0.668
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	-0.320	-0.640	-0.320	0.539	-1.243	-1.243	0.283	-0.640	0.539	4.438	-0.319
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	-1.675	-0.272	-0.360	-0.753	-0.360	-2.367	-0.935	1.585	2.602	1.585	0.337
KHETCHOUMIAN_TRIM24_TARGETS_UP KHETCHOUMIAN_TRIM24_TARGETS_UP	-0.411	-1.158	-0.411	-1.158	-0.411	-0.702	-1.158	-0.411	2.134	2.640	1.277
NAGASHIMA_EGF_SIGNALING_UP NAGASHIMA_EGF_SIGNALING_UP	-0.399	-0.399	-1.006	-0.235	-1.536	-1.006	-0.645	0.587	-0.399	4.493	1.156
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	-1.077	-0.241	0.371	-0.520	-0.241	-1.077	-0.520	-0.241	0.371	5.139	-0.518
HOSHIDA_LIVER_CANCER_SUBCLASS_S2 HOSHIDA_LIVER_CANCER_SUBCLASS_S2	-1.383	0.593	1.479	1.765	-1.383	-1.383	0.775	1.479	0.311	-1.055	-1.375
SUBTIL_PROGESTIN_TARGETS SUBTIL_PROGESTIN_TARGETS	-0.234	-0.828	0.984	0.984	-1.492	-1.492	0.380	-1.492	0.380	0.984	0.988
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	-2.130	0.923	0.420	-1.322	0.301	-2.669	0.420	0.420	1.382	1.935	-0.420
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	-0.828	-0.828	-1.492	-0.234	-0.828	-0.828	0.646	0.380	-0.234	3.619	0.988
ROSS_LEUKEMIA_WITH_MLL_FUSIONS ROSS_LEUKEMIA_WITH_MLL_FUSIONS	-1.707	0.724	-0.255	-0.255	-0.596	-2.363	-0.596	-0.397	0.520	3.608	0.729
RAMASWAMY_METASTASIS_UP RAMASWAMY_METASTASIS_UP	1.132	0.604	1.825	0.405	-1.271	-0.566	-0.359	0.846	0.405	-1.271	-2.729
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	0.530	1.964	2.868	0.406	-0.543	-1.755	-0.707	0.840	-0.707	-0.906	-1.745
ZHU_CMV_ALL_UP ZHU_CMV_ALL_UP	0.762	-0.312	-1.167	0.576	-1.167	-1.540	-1.540	3.240	0.762	0.976	-0.629
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	-0.416	-1.035	1.456	-0.668	-0.668	-1.571	-0.668	0.564	0.564	3.806	-0.664
GENTLES_LEUKEMIC_STEM_CELL_DN GENTLES_LEUKEMIC_STEM_CELL_DN	-0.787	-0.787	0.279	-0.787	-0.787	-0.787	0.279	-0.324	0.609	2.269	1.618
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	-0.262	0.344	0.481	0.837	-0.738	-2.194	0.837	1.875	1.057	-0.738	-2.798
HUMMEL_BURKITTS_LYMPHOMA_DN HUMMEL_BURKITTS_LYMPHOMA_DN	-0.621	-0.621	-0.223	-0.621	-0.621	-0.621	-0.621	1.385	2.069	1.385	-0.222
ZHU_CMV_24_HR_UP ZHU_CMV_24_HR_UP	0.679	0.326	-0.633	0.909	-0.911	-2.436	-0.911	3.467	0.326	0.484	-0.906
SMID_BREAST_CANCER_LUMINAL_A_UP SMID_BREAST_CANCER_LUMINAL_A_UP	0.435	-0.473	-1.364	-2.547	-0.691	1.366	-0.981	0.289	0.289	1.082	2.427
MORI_PRE_BI_LYMPHOCYTE_DN MORI_PRE_BI_LYMPHOCYTE_DN	-0.559	-0.369	-0.369	-1.643	-0.559	-1.643	-0.369	2.813	0.772	2.389	-0.555
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	-1.225	0.571	-0.755	-0.755	-1.990	1.180	-0.451	-0.256	-0.451	1.565	2.009
PARK_HSC_AND_MULTIPOTENT_PROGENITORS PARK_HSC_AND_MULTIPOTENT_PROGENITORS	0.226	0.226	0.654	1.320	-1.124	-1.124	-1.124	2.204	0.654	0.226	-1.860
AMIT_SERUM_RESPONSE_120_MCF10A AMIT_SERUM_RESPONSE_120_MCF10A	-1.241	-0.835	0.262	1.502	-1.819	-0.835	0.262	0.876	-0.546	3.226	-0.341
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	-0.465	0.559	-0.889	2.072	-1.190	-1.567	1.191	0.405	1.752	-0.323	-2.031
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	-0.624	-0.290	0.312	-0.624	-1.201	-2.164	-0.432	-0.875	1.985	2.346	1.359
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	-0.472	1.512	1.137	0.546	-0.472	-2.031	0.334	0.814	0.546	-0.782	-2.026
LIU_COMMON_CANCER_GENES LIU_COMMON_CANCER_GENES	-1.211	1.546	0.651	0.440	-0.810	-2.654	-0.329	1.205	0.651	0.651	-1.206
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	-0.451	-0.256	-0.451	0.571	-1.225	-1.990	0.351	2.001	2.001	0.351	-1.221
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	0.998	3.385	0.430	0.430	-1.090	-1.824	0.239	-0.373	0.239	-1.090	-0.647
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	-0.486	0.255	-1.819	-1.439	0.643	0.643	-1.439	-0.352	0.361	0.361	4.275
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	-1.872	1.661	0.716	0.545	0.281	-3.017	-0.322	0.716	0.545	0.914	-1.449
SCIBETTA_KDM5B_TARGETS_DN SCIBETTA_KDM5B_TARGETS_DN	-0.383	-0.244	0.994	-0.244	-0.842	-2.326	-1.198	1.277	3.202	-0.383	-0.573
HUANG_FOXA2_TARGETS_DN HUANG_FOXA2_TARGETS_DN	-0.893	-0.893	-1.575	-0.500	-0.500	-0.266	-0.893	0.898	0.898	2.780	0.902
MARZEC_IL2_SIGNALING_UP MARZEC_IL2_SIGNALING_UP	0.311	0.311	-0.291	1.765	0.311	-2.288	-1.787	-0.291	-0.792	3.154	-0.414
WIERENGA_STAT5A_TARGETS_GROUP1 WIERENGA_STAT5A_TARGETS_GROUP1	-0.412	-0.292	-0.761	0.311	-2.101	-2.101	-0.566	0.749	0.432	2.982	1.420
GALLUZZI_PERMEABILIZE_MITOCHONDRIA GALLUZZI_PERMEABILIZE_MITOCHONDRIA	-0.599	0.269	3.591	-0.336	0.749	-1.741	-0.336	1.083	-0.599	-0.599	-1.020
AFFAR_YY1_TARGETS_UP AFFAR_YY1_TARGETS_UP	-0.334	-1.335	-1.095	-0.712	-0.334	0.583	-0.889	-0.562	-0.562	1.439	4.754
ZHANG_PROLIFERATING_VS_QUIESCENT ZHANG_PROLIFERATING_VS_QUIESCENT	-0.271	0.814	0.814	0.334	-2.031	-1.259	-0.782	0.334	0.546	2.411	-1.255
SCHEIDEREIT_IKK_TARGETS SCHEIDEREIT_IKK_TARGETS	-0.704	0.332	-0.704	-0.272	-0.272	-0.704	0.706	3.361	0.706	-0.704	-0.702
LINDVALL_IMMORTALIZED_BY_TERT_UP LINDVALL_IMMORTALIZED_BY_TERT_UP	-0.374	-0.586	-2.779	0.581	0.581	-0.885	0.238	0.238	-0.586	0.388	3.597
HENDRICKS_SMARCA4_TARGETS_UP HENDRICKS_SMARCA4_TARGETS_UP	-0.921	-1.431	0.435	-0.578	0.435	-2.239	-0.348	-0.348	0.944	2.076	1.280
LEE_LIVER_CANCER_ACOX1_UP LEE_LIVER_CANCER_ACOX1_UP	-1.819	-0.344	0.262	-0.835	-0.546	-0.344	-0.835	0.262	-0.344	4.889	0.881
FAELT_B_CLL_WITH_VH3_21_DN FAELT_B_CLL_WITH_VH3_21_DN	-1.259	-0.782	-0.271	0.546	-0.271	-2.031	-0.472	1.137	1.938	1.512	-0.779
MIKKELSEN_ES_ICP_WITH_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K27ME3	0.476	-0.336	-1.024	-1.741	-0.599	2.987	1.083	-0.599	0.749	0.269	-1.020
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	-0.702	-0.702	-1.158	-1.907	0.389	1.271	-0.702	-0.228	-0.228	2.640	0.924
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	0.958	1.320	0.654	0.654	-1.865	-1.865	0.226	0.958	-0.392	-0.392	-1.120
LINDSTEDT_DENDRITIC_CELL_MATURATION_A LINDSTEDT_DENDRITIC_CELL_MATURATION_A	-0.762	-0.762	-0.762	-0.489	-0.301	-1.152	-0.489	-0.489	0.301	1.640	4.605
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	0.546	0.546	1.512	0.814	-2.031	-1.259	0.546	-0.271	0.334	0.334	-2.026
LU_TUMOR_ANGIOGENESIS_UP LU_TUMOR_ANGIOGENESIS_UP	-0.222	-1.036	0.398	-1.036	-1.036	-0.491	-0.491	-0.491	1.658	2.249	0.729
WANG_HCP_PROSTATE_CANCER WANG_HCP_PROSTATE_CANCER	-1.979	0.783	-0.617	-1.514	1.249	-1.143	-0.617	-0.301	0.301	2.892	0.789
MURAKAMI_UV_RESPONSE_6HR_UP MURAKAMI_UV_RESPONSE_6HR_UP	1.512	-0.765	-0.765	-0.765	-0.407	-1.409	0.216	3.191	-0.765	0.427	0.429
OSADA_ASCL1_TARGETS_DN OSADA_ASCL1_TARGETS_DN	-0.994	-0.462	-0.994	-0.204	-0.204	-0.204	-0.994	-0.462	0.426	3.813	0.775
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP	-0.336	-0.747	-1.760	0.752	-0.942	-0.583	-1.445	-0.447	1.774	3.240	0.610
HECKER_IFNB1_TARGETS HECKER_IFNB1_TARGETS	-0.279	-0.854	-0.606	-1.592	0.651	-0.606	-0.606	-1.176	0.324	1.692	3.674
BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE	-0.755	0.351	0.848	1.565	-0.755	-1.990	0.351	0.351	2.001	-1.225	-0.752
YAGI_AML_FAB_MARKERS YAGI_AML_FAB_MARKERS	-0.844	0.496	-0.310	0.766	-1.278	-1.278	-1.860	-0.672	1.104	3.444	0.629
APPIERTO_RESPONSE_TO_FENRETINIDE_DN APPIERTO_RESPONSE_TO_FENRETINIDE_DN	1.055	2.767	0.301	0.301	-0.513	-2.114	0.750	0.301	-0.513	-0.837	-1.323
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	-2.026	-0.533	0.818	0.818	-0.405	-2.440	0.660	2.160	1.191	-0.301	-1.091
LEE_LIVER_CANCER_E2F1_UP LEE_LIVER_CANCER_E2F1_UP	-0.786	-0.508	0.288	-0.786	-1.748	0.675	-1.181	0.288	-0.315	3.919	0.943
LEE_LIVER_CANCER_CIPROFIBRATE_UP LEE_LIVER_CANCER_CIPROFIBRATE_UP	-2.488	0.330	-0.452	-0.452	-0.452	0.519	-1.093	-0.715	0.519	2.607	1.374
MODY_HIPPOCAMPUS_PRENATAL MODY_HIPPOCAMPUS_PRENATAL	-0.373	1.370	1.798	0.684	-1.090	-1.824	-1.090	0.998	0.430	-0.650	-0.647
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	0.250	0.250	-1.855	-1.855	-0.860	0.405	0.250	0.846	-0.359	0.250	3.678
MUELLER_METHYLATED_IN_GLIOBLASTOMA MUELLER_METHYLATED_IN_GLIOBLASTOMA	-1.057	-1.057	-1.057	-0.624	0.254	0.453	0.254	-0.624	0.254	0.453	4.819
LY_AGING_PREMATURE_DN LY_AGING_PREMATURE_DN	-1.243	-0.640	1.301	1.301	-0.640	-1.243	-0.640	0.283	0.539	1.796	-0.638
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	-1.029	0.687	0.507	0.507	-1.381	-3.145	0.687	0.359	0.687	2.028	-0.747
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	-0.746	-0.746	-0.298	-0.746	0.304	-0.298	-0.746	0.655	0.304	4.058	-0.297
ALONSO_METASTASIS_UP ALONSO_METASTASIS_UP	0.396	2.555	0.396	1.321	0.301	-4.203	-0.829	0.301	-0.302	-0.517	-0.394
GAVIN_FOXP3_TARGETS_CLUSTER_P7 GAVIN_FOXP3_TARGETS_CLUSTER_P7	-1.151	-1.563	-0.404	-1.563	-0.268	-1.151	-0.268	1.731	1.419	1.731	0.677
STEARMAN_TUMOR_FIELD_EFFECT_UP STEARMAN_TUMOR_FIELD_EFFECT_UP	-0.477	-0.860	-0.860	-1.533	-0.477	-0.860	0.940	-0.250	0.940	2.876	0.617
BYSTROEM_CORRELATED_WITH_IL5_DN BYSTROEM_CORRELATED_WITH_IL5_DN	-1.571	-0.247	0.564	-0.416	0.362	-2.405	0.362	0.564	2.275	0.814	-1.030
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	-0.478	-0.834	-0.478	-0.638	-1.074	-1.074	0.628	-0.478	0.795	5.333	-0.346
HUMMERICH_SKIN_CANCER_PROGRESSION_UP HUMMERICH_SKIN_CANCER_PROGRESSION_UP	0.390	0.256	-0.751	-0.751	-1.053	-1.966	-0.751	0.557	-0.351	2.656	2.274
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	-0.412	1.209	-0.412	1.516	-0.614	-2.400	-0.888	0.937	0.937	0.701	-1.732
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	0.362	-0.663	3.556	0.762	-0.663	-0.663	-0.663	-0.247	0.362	-0.663	-0.246
LIU_VMYB_TARGETS_UP LIU_VMYB_TARGETS_UP	-0.538	-0.727	0.610	-0.388	-0.727	-3.227	0.610	0.990	3.080	0.331	-0.533
BILANGES_SERUM_SENSITIVE_VIA_TSC1 BILANGES_SERUM_SENSITIVE_VIA_TSC1	-0.870	0.236	-0.870	0.236	0.236	1.436	-0.378	-0.870	0.236	-0.870	2.732
AMIT_EGF_RESPONSE_120_HELA AMIT_EGF_RESPONSE_120_HELA	-0.606	-0.390	0.790	-0.910	-1.332	-1.927	0.372	1.375	-0.390	3.008	-0.238
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	-0.442	-1.308	-0.442	0.657	-0.652	-1.803	-0.289	1.144	0.313	3.880	-0.648
BHAT_ESR1_TARGETS_VIA_AKT1_DN BHAT_ESR1_TARGETS_VIA_AKT1_DN	-1.771	-0.633	0.326	-0.911	-0.633	-1.280	-0.427	0.484	0.909	0.909	3.481
IKEDA_MIR133_TARGETS_UP IKEDA_MIR133_TARGETS_UP	-1.824	-0.373	-0.650	0.430	0.430	-1.824	1.370	1.370	0.239	0.998	-0.647
VERRECCHIA_RESPONSE_TO_TGFB1_C4 VERRECCHIA_RESPONSE_TO_TGFB1_C4	-0.456	0.187	-0.456	-0.456	-0.456	-0.456	0.187	1.875	-0.456	-0.456	2.753
HUMMERICH_MALIGNANT_SKIN_TUMOR_UP HUMMERICH_MALIGNANT_SKIN_TUMOR_UP	-0.746	-0.298	1.128	-0.746	3.182	-0.298	-0.298	-0.746	0.655	-0.298	-0.744
FINETTI_BREAST_CANCER_KINOME_RED FINETTI_BREAST_CANCER_KINOME_RED	-0.663	-0.247	-0.663	-0.247	-0.247	-0.663	0.762	2.696	1.292	-0.663	-0.661
MOOTHA_TCA MOOTHA_TCA	0.762	2.696	1.292	-0.247	-0.247	-0.663	-0.247	-0.663	-0.663	-0.663	-0.661
WILCOX_RESPONSE_TO_PROGESTERONE_UP WILCOX_RESPONSE_TO_PROGESTERONE_UP	-0.447	-0.775	-0.447	0.500	-0.993	-3.494	0.809	1.430	1.202	1.430	-0.589
NADLER_OBESITY_UP NADLER_OBESITY_UP	-0.274	-0.715	-0.274	-0.715	-1.642	-0.452	-0.452	1.039	1.039	3.629	-1.088
IVANOVA_HEMATOPOIESIS_STEM_CELL IVANOVA_HEMATOPOIESIS_STEM_CELL	-0.946	-0.353	-2.069	-0.596	-0.463	-1.168	-0.353	1.227	1.661	3.039	-0.348
JAZAG_TGFB1_SIGNALING_UP JAZAG_TGFB1_SIGNALING_UP	-0.617	1.002	0.593	0.301	-0.438	-1.514	-2.568	2.511	0.301	1.002	-0.843
YU_MYC_TARGETS_UP YU_MYC_TARGETS_UP	-0.624	0.715	1.861	0.254	-0.624	-1.782	0.715	-0.624	1.861	-0.624	-1.053
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	-0.264	1.393	2.356	-0.458	-1.654	-2.760	0.442	-1.130	-0.264	0.692	0.565
BOYLAN_MULTIPLE_MYELOMA_C_D_UP BOYLAN_MULTIPLE_MYELOMA_C_D_UP	0.414	1.097	0.710	2.454	-0.977	-3.027	-0.301	-0.301	-0.566	0.710	-1.244
BURTON_ADIPOGENESIS_PEAK_AT_2HR BURTON_ADIPOGENESIS_PEAK_AT_2HR	-1.158	-0.411	-0.702	0.625	-1.158	-0.702	-0.228	-1.158	0.625	2.640	1.684
LY_AGING_OLD_DN LY_AGING_OLD_DN	-0.382	0.612	2.895	0.612	-1.501	-1.501	-0.382	0.397	-0.382	0.877	-1.496
SESTO_RESPONSE_TO_UV_C7 SESTO_RESPONSE_TO_UV_C7	0.737	-0.647	-0.264	0.342	-2.903	-1.999	0.519	0.997	0.342	1.297	0.345
WINTER_HYPOXIA_UP WINTER_HYPOXIA_UP	0.456	2.346	0.840	0.632	-1.621	-2.164	-1.201	0.840	0.312	-0.875	0.315
CHEBOTAEV_GR_TARGETS_DN CHEBOTAEV_GR_TARGETS_DN	0.311	-0.566	-0.566	-1.661	-0.292	-0.292	-1.003	-0.761	-0.292	1.166	4.647
ROESSLER_LIVER_CANCER_METASTASIS_DN ROESSLER_LIVER_CANCER_METASTASIS_DN	0.317	0.781	-0.810	0.521	-0.285	-1.294	-1.294	3.398	-0.810	0.781	-0.806
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	-1.117	-0.341	2.096	0.598	-1.580	-1.117	-1.117	1.387	1.087	0.598	-0.771
ZHAN_MULTIPLE_MYELOMA_PR_DN ZHAN_MULTIPLE_MYELOMA_PR_DN	-0.782	-1.259	0.334	-0.271	-0.472	-2.031	-0.271	0.546	1.137	2.929	-0.269
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	-0.885	0.238	0.238	-0.374	-1.302	-2.779	0.388	1.416	1.096	1.416	0.240
LEE_NEURAL_CREST_STEM_CELL_UP LEE_NEURAL_CREST_STEM_CELL_UP	-0.381	-0.886	-0.381	-2.698	-0.275	1.126	-1.133	-0.515	0.329	1.864	2.165
SESTO_RESPONSE_TO_UV_C0 SESTO_RESPONSE_TO_UV_C0	-2.071	0.542	2.031	1.715	-0.479	-1.595	0.542	0.928	-0.479	-0.668	-0.903
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP	0.304	-0.298	-0.746	0.655	-0.746	-0.746	-0.746	0.304	1.713	1.713	-0.744
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53 AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	-1.190	-0.323	-1.190	0.952	-1.190	-1.567	-0.651	0.405	1.191	2.418	0.959
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	-0.300	2.069	0.302	-0.549	-0.300	-1.658	0.527	-0.549	1.594	0.302	-1.653
OKAWA_NEUROBLASTOMA_1P36_31_DELETION OKAWA_NEUROBLASTOMA_1P36_31_DELETION	0.217	1.356	1.932	0.217	-0.911	-0.911	0.217	-0.911	-0.911	-0.406	0.876
KIM_GERMINAL_CENTER_T_HELPER_UP KIM_GERMINAL_CENTER_T_HELPER_UP	-0.810	-1.783	0.651	1.205	0.274	-2.654	0.440	0.651	0.651	0.906	-0.524
JIANG_VHL_TARGETS JIANG_VHL_TARGETS	0.419	0.278	1.644	0.806	-1.005	-3.568	0.278	0.595	0.419	0.419	-0.999
SCHLOSSER_SERUM_RESPONSE_UP SCHLOSSER_SERUM_RESPONSE_UP	-0.566	0.945	0.432	0.311	-0.412	-1.661	0.578	1.166	1.679	-0.412	-3.286
GENTILE_UV_RESPONSE_CLUSTER_D1 GENTILE_UV_RESPONSE_CLUSTER_D1	-0.272	-0.704	-0.704	-0.704	-0.704	-0.704	0.332	1.206	1.206	1.821	-0.271
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	-0.691	-0.981	-0.981	-0.691	-0.473	2.826	-0.473	-0.473	-0.691	0.615	2.839
HOOI_ST7_TARGETS_DN HOOI_ST7_TARGETS_DN	-1.482	0.388	-0.645	0.272	-0.469	-2.414	-0.645	0.388	0.697	2.950	1.119
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN	-0.497	3.495	-0.497	-0.497	-0.497	0.166	-0.497	0.166	-0.497	1.052	0.167
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	0.261	-0.595	-0.761	-1.192	1.507	-0.345	-1.784	-0.959	0.353	0.901	3.217
BOSCO_TH1_CYTOTOXIC_MODULE BOSCO_TH1_CYTOTOXIC_MODULE	0.467	-0.393	-2.225	-2.225	-0.272	0.333	-0.393	-0.552	0.628	1.837	1.848
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	0.332	-0.704	-0.272	-0.704	-0.704	-0.704	0.332	0.332	1.821	1.821	-0.702
HASINA_NOL7_TARGETS_UP HASINA_NOL7_TARGETS_UP	-0.538	-0.538	-0.176	-0.176	-0.538	-0.538	-0.176	-0.538	0.476	4.273	-0.176
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	-0.461	-0.461	1.830	-0.625	-0.331	-3.439	0.384	1.553	1.067	-0.331	-0.620
MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP	-0.497	-0.497	0.524	-0.497	-0.497	-0.497	-0.497	0.166	3.495	0.524	0.167
KALMA_E2F1_TARGETS KALMA_E2F1_TARGETS	-0.456	-0.456	1.875	0.578	-0.456	-0.456	-0.456	1.875	0.187	-0.456	-0.454
NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS	-0.538	-0.538	-0.538	-0.176	0.967	2.370	-0.538	-0.538	-0.538	-0.176	0.970
